BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31144406)

  • 1. Carcinogen-induced tumors in SFN-transgenic mice harbor a characteristic mutation spectrum of human lung adenocarcinoma.
    Kim Y; Shiba-Ishii A; Ramirez K; Muratani M; Sakamoto N; Iijima T; Noguchi M
    Cancer Sci; 2019 Aug; 110(8):2431-2441. PubMed ID: 31144406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stratifin accelerates progression of lung adenocarcinoma at an early stage.
    Shiba-Ishii A; Kim Y; Shiozawa T; Iyama S; Satomi K; Kano J; Sakashita S; Morishita Y; Noguchi M
    Mol Cancer; 2015 Jul; 14():142. PubMed ID: 26223682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stratifin Inhibits SCF
    Shiba-Ishii A; Hong J; Hirokawa T; Kim Y; Nakagawa T; Sakashita S; Sakamoto N; Kozuma Y; Sato Y; Noguchi M
    Clin Cancer Res; 2019 May; 25(9):2809-2820. PubMed ID: 30728155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of stratifin in early progression of lung adenocarcinoma and its potential therapeutic relevance.
    Shiba-Ishii A
    Pathol Int; 2021 Oct; 71(10):655-665. PubMed ID: 34324245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aberrant stratifin overexpression is regulated by tumor-associated CpG demethylation in lung adenocarcinoma.
    Shiba-Ishii A; Noguchi M
    Am J Pathol; 2012 Apr; 180(4):1653-62. PubMed ID: 22310466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
    Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
    J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased susceptibility to the tobacco carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in transgenic mice overexpressing c-myc and epidermal growth factor in alveolar type II cells.
    Ehrhardt A; Bartels T; Klocke R; Paul D; Halter R
    J Cancer Res Clin Oncol; 2003 Feb; 129(2):71-5. PubMed ID: 12669230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma.
    Kim Y; Shiba-Ishii A; Nakagawa T; Iemura SI; Natsume T; Nakano N; Matsuoka R; Sakashita S; Lee S; Kawaguchi A; Sato Y; Noguchi M
    Oncogene; 2018 Oct; 37(40):5387-5402. PubMed ID: 29880877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.
    Zhou LN; Li SC; Li XY; Ge H; Li HM
    Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
    Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
    Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional role of RBM10 in lung adenocarcinoma proliferation.
    Sun X; Jia M; Sun W; Feng L; Gu C; Wu T
    Int J Oncol; 2019 Feb; 54(2):467-478. PubMed ID: 30483773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miRNA-125b regulates apoptosis of human non-small cell lung cancer via the PI3K/Akt/GSK3β signaling pathway.
    Wang Y; Zhao M; Liu J; Sun Z; Ni J; Liu H
    Oncol Rep; 2017 Sep; 38(3):1715-1723. PubMed ID: 28713974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mutational landscapes of genetic and chemical models of Kras-driven lung cancer.
    Westcott PM; Halliwill KD; To MD; Rashid M; Rust AG; Keane TM; Delrosario R; Jen KY; Gurley KE; Kemp CJ; Fredlund E; Quigley DA; Adams DJ; Balmain A
    Nature; 2015 Jan; 517(7535):489-92. PubMed ID: 25363767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High expression of stratifin is a universal abnormality during the course of malignant progression of early-stage lung adenocarcinoma.
    Shiba-Ishii A; Kano J; Morishita Y; Sato Y; Minami Y; Noguchi M
    Int J Cancer; 2011 Nov; 129(10):2445-53. PubMed ID: 21207417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-212-5p exerts tumor promoter function by regulating the Id3/PI3K/Akt axis in lung adenocarcinoma cells.
    Chen FF; Sun N; Wang Y; Xi HY; Yang Y; Yu BZ; Li XJ
    J Cell Physiol; 2020 Oct; 235(10):7273-7282. PubMed ID: 32039486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type of TP53 mutation influences oncogenic potential and spectrum of associated K-ras mutations in lung-specific transgenic mice.
    Duan W; Gao L; Kalvala A; Aguila B; Brooks C; Mo X; Ding H; Shilo K; Otterson GA; Villalona-Calero MA
    Int J Cancer; 2019 Nov; 145(9):2418-2426. PubMed ID: 30873587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syngeneic tobacco carcinogen-induced mouse lung adenocarcinoma model exhibits PD-L1 expression and high tumor mutational burden.
    Stabile LP; Kumar V; Gaither-Davis A; Huang EH; Vendetti FP; Devadassan P; Dacic S; Bao R; Steinman RA; Burns TF; Bakkenist CJ
    JCI Insight; 2021 Feb; 6(3):. PubMed ID: 33351788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low BIK outside-inside-out interactive inflammation immune-induced transcription-dependent apoptosis through FUT3-PMM2-SQSTM1-SFN-ZNF384.
    Huang J; Wang L; Jiang M; Chen Q; Zhang X; Wang Y; Jiang Z; Zhang Z
    Immunol Res; 2016 Apr; 64(2):461-9. PubMed ID: 26423071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miRNA-223 is an anticancer gene in human non-small cell lung cancer through the PI3K/AKT pathway by targeting EGFR.
    Ma HP; Kong WX; Li XY; Li W; Zhang Y; Wu Y
    Oncol Rep; 2019 Mar; 41(3):1549-1559. PubMed ID: 30747217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of stratifin (14-3-3 sigma) in adenocarcinoma of gallbladder: A novel prognostic biomarker.
    Sirivatanauksorn V; Dumronggittigule W; Dulnee B; Srisawat C; Sirivatanauksorn Y; Pongpaibul A; Masaratana P; Somboonyosdech C; Sripinitchai S; Kositamongkol P; Mahawithitwong P; Tovikkai C; Sangserestid P; Limsrichamrern S
    Surg Oncol; 2020 Mar; 32():57-62. PubMed ID: 31751820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.